CDKN2A and ovarian cancer: In contrast to pRb ISI, pRb PPC (P=0.21) as well as both p16INK4a ISI (P=0.49) and PPC (P=0.25) were not associated with prognosis in this group of optimally debulked ovarian cancer patients.